Baldwin Investment Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baldwin Investment Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$563,000
-6.8%
30,824
-7.1%
0.10%
-13.4%
Q4 2020$604,000
-11.2%
33,184
-12.9%
0.12%
-25.2%
Q3 2020$680,000
-6.5%
38,117
-6.0%
0.16%
-30.3%
Q2 2020$727,000
+23.2%
40,567
+4.4%
0.23%
+12.3%
Q1 2020$590,000
-26.0%
38,867
-3.8%
0.20%
-4.7%
Q4 2019$797,000
+25.5%
40,417
+9.5%
0.21%
+15.1%
Q3 2019$635,000
+0.6%
36,927
+3.6%
0.18%
+1.6%
Q2 2019$631,000
-8.7%
35,634
+5.0%
0.18%
-12.5%
Q1 2019$691,00033,9340.21%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders